BCL-2 drugs for Multiple Myeloma
3 tracked BCL-2 drugs in the Multiple Myeloma race. The class explanation lives on the BCL-2 page; the full indication pipeline across every mechanism is on the Multiple Myeloma page.
1 Phase 32 Phase 1/2
Head-to-head evidence: Lisaftoclax vs Surzetoclax · Lisaftoclax vs Venetoclax